A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Office of Technology Licensing

Office of Technology Licensing (OTL)
The Office of Technology Licensing (OTL) is an institution wide resource that works closely with City of Hope inventors to identify, protect, and create effective strategies to commercially advance their inventions and technologies.
 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices.
 
Have you created a novel invention during the course of your research and would like to learn about how to build a start-up company around your discovery? Contact OTL and we can guide you through the necessary steps and help you start your company.
 
City of Hope's main focus is on translational research and developing new therapies. To that end we partner extensively with industry in hundreds of clinical trials and sponsored research projects each year. To support this aspiration, the CATD provides cGMP manufacturing of biologics at substantially reduced costs as compared with CMOs.

Below is a brief overview of the core services the Office of Technology Licensing offers to City of Hope investigators.
 
  • Meeting with City of Hope investigators to discuss new discoveries and inventions
 
  • Developing strategies to protect discoveries and inventions with patents, trademarks and copyrights while preserving academic values
 
  • Commercializing inventions and discoveries with industry partners to create novel therapeutics, diagnostics and research tools
 
  • Creating start-up companies around technologies developed at City of Hope
 
  • Negotiating and formalizing partnership agreements such as industry sponsored research, material transfer, confidentiality and inter-institutional agreements
 
  • Compliance with City of Hope policies and procedures related to materials, confidentiality and intellectual property, along with input from other teams at City of Hope
 
  • Organizing educational events focused on intellectual property, technology commercialization and entrepreneurship
 
 

About OTL

The OTL Team
The Office of Technology Licensing (OTL) is an institution-wide resource that works closely with City of Hope inventors to identify, protect and create effective strategies to realize the commercial potential of their inventions and technologies.
 
To achieve this goal, the OTL has several responsibilities. The OTL is responsible for developing intellectual property protection strategies that include the utilization of patents, trademarks and copyrights. The OTL also identifies and develops strategic partnerships with companies for potential licensing opportunities as well as collaborations to further develop these technologies. When a company makes the decision to license a technology, the OTL negotiates mutually beneficial license agreements to ensure that the commercial partner will commit and devote necessary resources to enable the successful development of these technologies and that the City of Hope will receive fair royalty rates and fees. The revenue generated from licenses is shared with our inventors and also with City of Hope to support future research.
 
We also help our entrepreneurial inventors to start their own companies around platform technologies. We have developed relationships with various investors including local angel investors and venture capitalists to encourage the formation of start-up companies.
 
In addition to the OTL’s mission to commercialize technologies, we devote a large portion of our time to catalyze research collaborations through the management and execution of material transfer agreements, confidential disclosure agreements and research collaboration agreements.

Meet the Team

The City of Hope Office of Technology Licensing team brings a wide array of experiences from both academia and industry in life sciences. The combination of each team member’s unique experience and background creates a well-rounded team. Our team is here to serve our investigators to assist in the advancement of their research and inventions. Feel free to contact members of the team with questions, comments or concerns about the OTL.
Overview
Office of Technology Licensing
City of Hope
1500 E. Duarte Rd.
Modular 101
Duarte, CA 91010
 
 
 
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

City of Hope Campus Map
 
 
 
 
 
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • For breast cancer survivors, a common worry is a recurrence of their cancer. Currently, these patients are screened with regular mammograms, but there’s no way to tell who is more likely to have a recurrence and who is fully cleared of her cancer. A new blood test – reported in Cancer Research, a journal of the...
  • Metastasis — the spreading of cancer cells from a primary tumor site to other parts of the body — generally leads to poorer outcomes for patients, so oncologists and researchers are constantly seeking new ways to detect and thwart this malicious process. Now City of Hope researchers may have identified a substa...
  • Deodorant, plastic bottles, grilled foods, artificial sweeteners, soy products … Do any of these products really cause cancer? With so many cancer myths and urban legends out there, why not ask the experts? They can debunk cancer myths while sharing cancer facts that matter, such as risk factors, preventi...
  • Cancer risk varies by ethnicity, as does the risk of cancer-related death. But the size of those differences can be surprising, highlighting the health disparities that exist among various ethnic groups in the United States. Both cancer incidence and death rates for men are highest among African-Americans, acco...
  • George Winston, known worldwide for his impressionistic, genre-defying music, considers music to be his first language, and admits he often stumbles over words – especially when he attempts languages other than English. There’s one German phrase he’s determined to perfect, however: danke schön. Winston thinks h...
  • Few decisions are more important than those involving health care, and few decisions can have such lasting impact, not only on oneself but on relatives and loved ones. Those choices, especially, should be made in advance – carefully, deliberately, free of pain and stress, and with much weighing of values and pr...
  • Using a card game to make decisions about health care, especially as those decisions relate to the end of life, would seem to be a poor idea. It isn’t. The GoWish Game makes those overwhelming, but all-important decisions not just easy, but natural. On each card of the 36-card deck is listed what seriously ill,...
  • Young adults and adolescents with cancer face unique challenges both during their treatment and afterward. Not only are therapies for children and older adults not always appropriate for them, they also must come to terms with the disease and treatment’s impact on their relationships, finances, school or ...
  • Breast cancer is the most common cancer, other than skin cancer, among women in the United States. It’s also the second-leading cause of cancer death, behind lung cancer. In the past several years, various task force recommendations and studies have questioned the benefits of broad screening guidelines fo...
  • Paternal age and the health effects it has on potential offspring have been the focus of many studies, but few have examined the effect parental age has on the risk of adult-onset hormone-related cancers (breast cancer, ovarian cancer and endometrial cancer). A team of City of Hope researchers, lead by Yani Lu,...
  • Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal h...
  • Myeloproliferative neoplasms can’t be narrowed down to a single cancer, but they can be described by a defining characteristic: too many blood cells. The diseases bring with them a host of frustrating, potentially life-altering symptoms, and management of the diseases and their symptoms is crucial. An upcoming ...
  • More than 18,000 researchers, clinicians, advocates and other professionals will convene at the 105th American Association for Cancer Research (AACR) annual meeting taking place in San Diego from April 5 to 9. With more than 6,000 findings being presented over this five-day period, the amount of information can...
  • Cancer of the prostate is the No. 2 cancer killer of men, behind lung cancer, accounting for more than 29,000 deaths annually in this country. But because prostate cancer advances slowly, good prostate health and early detection can make all the difference. Many prostate cancer tumors don’t require immedi...
  • Despite advances made in detecting and treating nonsmall cell lung cancer, its prognosis remains grim. Even patients whose cancers are caught at their earliest stage have only a 50 percent chance of five-year survival. This poor prognosis is due in part to the cancer’s ability to resist treatment, renderi...